Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,796.00
(
0.00%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
109.73
(
2.95%
)
Bitcoin
70,187.10
(
-1.48%
)
News Focus
News Focus
Post# of 177
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: oc631 post# 101

Tuesday, 12/14/2010 10:50:18 AM

Tuesday, December 14, 2010 10:50:18 AM

Post# of 177
VRUS is not the first company to test an HCV drug with ribavirin without interferon. Idera has been doing it since 2009 (http://clinicaltrials.gov/ct2/show/NCT00990938 ), and Coley Pharmaceuticals (acquired by PFE) did it several years ago.

VRUS is the first company to test a second-generation nuke in this manner, however.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now